[1] |
Thariat J, Hannoun-Levi JM, Myint AS, et al. Past, present, and future of radiotherapy for the benefit of patients. Nat Rev Clin Oncol, 2013; 10, 52−60. doi: 10.1038/nrclinonc.2012.203 |
[2] |
Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer, 2004; 4, 737−47. doi: 10.1038/nrc1451 |
[3] |
Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer, 2011; 11, 239−53. doi: 10.1038/nrc3007 |
[4] |
Victor CTS, Rech AJ, Maity A, et al. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature, 2015; 520, 373−7. doi: 10.1038/nature14292 |
[5] |
Moncharmont C, Levy A, Guy JB, et al. Radiation-enhanced cell migration/invasion process: a review. Crit Rev Oncol/Hematol, 2014; 92, 133−42. doi: 10.1016/j.critrevonc.2014.05.006 |
[6] |
Vilalta M, Rafat M, Graves EE. Effects of radiation on metastasis and tumor cell migration. Cell Mol Life Sci, 2016; 73, 2999−3007. doi: 10.1007/s00018-016-2210-5 |
[7] |
Lee SY, Jeong EK, Ju MK, et al. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer, 2017; 16, 10. doi: 10.1186/s12943-016-0577-4 |
[8] |
Thiery JP, Acloque H, Huang RYJ, et al. Epithelial-mesenchymal transitions in development and disease. Cell, 2009; 139, 871−90. doi: 10.1016/j.cell.2009.11.007 |
[9] |
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol, 2014; 15, 178−96. doi: 10.1038/nrm3758 |
[10] |
Li MJ, Xiong D, Huang H, et al. Ezrin promotes the proliferation, migration, and invasion of ovarian cancer cells. Biomed Environ Sci, 2021; 34, 139−51. |
[11] |
Sannino G, Marchetto A, Kirchner T, et al. Epithelial-to-mesenchymal and mesenchymal-to-epithelial transition in mesenchymal tumors: a paradox in sarcomas? Cancer Res, 2017; 77, 4556−61. doi: 10.1158/0008-5472.CAN-17-0032 |
[12] |
Mittal V. Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol, 2018; 13, 395−412. doi: 10.1146/annurev-pathol-020117-043854 |
[13] |
Yu Y, Luo W, Yang ZJ, et al. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition. Mol Cancer, 2018; 17, 70. doi: 10.1186/s12943-018-0818-9 |
[14] |
Siraj AK, Pratheeshkumar P, Divya SP, et al. TGFβ-induced SMAD4-dependent apoptosis proceeded by EMT in CRC. Mol Cancer Ther, 2019; 18, 1312−22. doi: 10.1158/1535-7163.MCT-18-1378 |
[15] |
Akhurst RJ, Hata A. Targeting the TGFβ signalling pathway in disease. Nat Rev Drug Discov, 2012; 11, 790−811. doi: 10.1038/nrd3810 |
[16] |
Seoane J, Gomis RR. TGF-β family signaling in tumor suppression and cancer progression. Cold Spring Harb Perspect Biol, 2017; 9, a022277. doi: 10.1101/cshperspect.a022277 |
[17] |
Farhood B, Khodamoradi E, Hoseini-Ghahfarokhi M, et al. TGF-β in radiotherapy: mechanisms of tumor resistance and normal tissues injury. Pharmacol Res, 2020; 155, 104745. doi: 10.1016/j.phrs.2020.104745 |
[18] |
Zhou YC, Liu JY, Li J, et al. Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition. Int J Radiat Oncol Biol Phys, 2011; 81, 1530−7. doi: 10.1016/j.ijrobp.2011.06.1956 |
[19] |
Chen ZY, Gao H, Dong Z, et al. NRP1 regulates radiation-induced EMT via TGF-β/Smad signaling in lung adenocarcinoma cells. Int J Radiat Biol, 2020; 96, 1281−95. doi: 10.1080/09553002.2020.1793015 |
[20] |
Carl C, Flindt A, Hartmann J, et al. Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway. Cell Mol Life Sci, 2016; 73, 427−43. doi: 10.1007/s00018-015-2003-2 |
[21] |
Park HR, Choi YJ, Kim JY, et al. Repeated irradiation with γ-ray induces cancer stemness through TGF-β-DLX2 signaling in the A549 human lung cancer cell line. Int J Mol Sci, 2021; 22, 4284. doi: 10.3390/ijms22084284 |
[22] |
Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell, 2009; 136, 215−33. doi: 10.1016/j.cell.2009.01.002 |
[23] |
Chang SC, Sun GL, Zhang D, et al. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4. Cell Death Dis, 2020; 11, 592. doi: 10.1038/s41419-020-02789-z |
[24] |
Li QZ, Cheng Q, Chen ZG, et al. MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-β1. Oncol Rep, 2016; 35, 1125−34. doi: 10.3892/or.2015.4432 |
[25] |
Wang ZH, Zhang H, Zhang P, et al. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma. Tumour Biol, 2016; 37, 7633−44. doi: 10.1007/s13277-015-4653-y |
[26] |
Metheetrairut C, Slack FJ. MicroRNAs in the ionizing radiation response and in radiotherapy. Curr Opin Genet Devel, 2013; 23, 12−9. doi: 10.1016/j.gde.2013.01.002 |
[27] |
Ding N, Wu X, He JP, et al. Detection of novel human MiRNAs responding to X-ray irradiation. J Radiat Res, 2011; 52, 425−32. doi: 10.1269/jrr.10158 |
[28] |
Liu Z, Liang X, Li XP, et al. MiRNA-21 functions in ionizing radiation-induced epithelium-to-mesenchymal transition (EMT) by downregulating PTEN. Toxicol Res, 2019; 8, 328−40. doi: 10.1039/C9TX00019D |
[29] |
Wang D, Liu Z, Yan ZY, et al. MiRNA-155-5p inhibits epithelium-to-mesenchymal transition (EMT) by targeting GSK-3β during radiation-induced pulmonary fibrosis. Arch Biochem Biophy, 2021; 697, 108699. doi: 10.1016/j.abb.2020.108699 |
[30] |
Chang L, Hu WT, Ye CY, et al. miR-3928 activates ATR pathway by targeting Dicer. RNA Biol, 2012; 9, 1247−54. doi: 10.4161/rna.21821 |
[31] |
Hu WT, Xu S, Yao B, et al. MiR-663 inhibits radiation-induced bystander effects by targeting TGFB1 in a feedback mode. RNA Biol, 2014; 11, 1189−98. doi: 10.4161/rna.34345 |
[32] |
He JP, Feng X, Hua JR, et al. miR-300 regulates cellular radiosensitivity through targeting p53 and apaf1 in human lung cancer cells. Cell Cycl, 2017; 16, 1943−53. doi: 10.1080/15384101.2017.1367070 |
[33] |
Andarawewa KL, Erickson AC, Chou WS, et al. Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor β-induced epithelial to mesenchymal transition. Cancer Res, 2007; 67, 8662−70. doi: 10.1158/0008-5472.CAN-07-1294 |
[34] |
Gu YQ, Zhang B, Gu GL, et al. Metformin increases the chemosensitivity of pancreatic cancer cells to gemcitabine by reversing EMT through regulation DNA methylation of miR-663. Onco Targets Ther, 2020; 13, 10417−29. doi: 10.2147/OTT.S261570 |
[35] |
Shih JY, Yang PC. The EMT regulator slug and lung carcinogenesis. Carcinogenesis, 2011; 32, 1299−304. doi: 10.1093/carcin/bgr110 |
[36] |
Zhao LQ, Lu XB, Cao Y. MicroRNA and signal transduction pathways in tumor radiation response. Cell Signal, 2013; 25, 1625−34. doi: 10.1016/j.cellsig.2013.04.004 |
[37] |
Ding N, Hua JR, He JP, et al. The role of MiR-5094 as a proliferation suppressor during cellular radiation response via downregulating STAT5b. J Cancer, 2020; 11, 2222−33. doi: 10.7150/jca.39679 |
[38] |
Song M, Xie DF, Gao SS, et al. A biomarker panel of radiation-upregulated miRNA as signature for ionizing radiation exposure. Life (Basel), 2020; 10, 361. |
[39] |
Hao Y, Baker D, Ten Dijke P. TGF-β-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci, 2019; 20, 2767. doi: 10.3390/ijms20112767 |
[40] |
Okada T, Kamada T, Tsuji H, et al. Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS). J Radiat Res, 2010; 51, 355−64. doi: 10.1269/jrr.10016 |